Establishment Labs Corp (ESTA): Market Cap to Revenue

Symbol and logo of brand Establishment Labs Corp (ESTA)

Establishment Labs (ESTA) previously experienced stagnation but has now entered an expansion phase, particularly following its entry into the US market. The company's average P/S on GURU.Markets analytics reflects this trend, with the current metric standing at 7.80. Growth is driven by surgeons' confidence in implant safety, while the Motiva digital ecosystem, which connects clinics with the vendor, ensures business resilience.

ESTA Establishment Labs Corp P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for Motiva (ESTA)

- share price and consensus valuation forecast:
Price Performance Chart establishmentlabs.com|ESTA - Price Target Chart
- stock exchange capitalization data:
Market Valuation Motiva|ESTA - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Establishment Labs|ESTA - Book Capitalization|Capitalization to Book Value Ratio establishmentlabs.com|ESTA - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Establishment Labs|ESTA - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Establishment Labs Inc|ESTA - Company Aggregate Debts|Debts to Book Capitalization Motiva|ESTA - Company Long-Term Debt|Company Short-Term Debt Establishment Labs|Intermediate Coverage Ratio establishmentlabs.com
- earnings and multiples data:
ESTA - Net Profit|Expected Net Profit Establishment Labs|ESTA - Price to Earnings Ratio|Forward Price to Earnings Multiple Establishment Labs Corp|ESTA - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Motiva|ESTA - Operating profit EBITDA|Net earnings per share for the last four quarters Establishment Labs|ESTA - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months establishmentlabs.com|ESTA - Earnings per share growth in current year|Expected earnings per share growth for next year Establishment Labs
- issuer revenue and sales details:
ESTA - Revenue and Sales Volume|Company Expected Sales Volume establishmentlabs.com|ESTA - Price-to-Revenue Ratio|Market Cap to Projected Revenue Motiva
General company analysis:ESTA establishmentlabs.com
Core merchandise of Establishment Labs

The P/S multiple determines the market value of a business per unit of generated revenue, allowing for an assessment of the asset's overvaluation relative to its actual operating income. Analyzing the price-to-sales ratio serves as a portfolio stress-testing tool, revealing the vulnerability of Establishment Labs (ESTA) to geopolitical disruptions in raw material supplies and patent protection complexities, which directly impact sales stability.

Competitors of Establishment Labs

BSX (bostonscientific.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Edwards Lifesciences Corporation EW|RMD - Market Cap to Revenue|OmniPod - P/S Multiple|Price to Sales Zimmer Biomet Holdings|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (Globus Medical) - P/S Multiple|TransMedics Group Inc (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion Corp AORT|P/S Multiple ENOV (Enovis Corporation)|P/S Multiple integralife.com IART|BBNX - Price-to-Revenue Ratio|IRMD: Price-to-Revenue Ratio|EMBC (Embecta Inc.) - Market Cap to Revenue|Tandem Corp - Market Capitalization-to-Revenue Ratio|AXGN (AxoGen, Inc.) - P/S Multiple|Price to Sales si-bone.com SIBN|Price-to-Revenue Ratio Orthofix (OFIX)|Bioventus Inc (BVS) - Price-to-Revenue Multiple|OrthoPediatrics - Market Cap to Revenue|P/S Multiple Treace Corp TMCI|Strata Critical Medical Inc - P/S Multiple|Price-to-Revenue Coefficient carlsmed.com CARL|RxSight (RXST) - Price-to-Revenue Ratio|Price-to-Sales Ratio CLPT (ClearPoint Neuro)|Price-to-Revenue Ratio Stereotaxis Corp|Market Cap to Revenue Neuronetics, Inc (STIM)|P/S Multiple SGHT|OBIO - Price to Sales|Price-to-Revenue Ratio Anika Therapeutics, Inc. ANIK|NSPR: Market Cap to Revenue Ratio|ZJYL: Market Cap to Revenue|Vivani Medical, Inc. - Market Cap to Sales Volume|XTNT: P/S Multiple|Price to Sales n1mtc.com (NMTC)|Price-to-Revenue Ratio Modular Medical Inc|Myomo Inc. (MYO) - Price-to-Revenue Coefficient|Market Cap to Revenue COCH (Envoy Medical, Inc)|Market Cap to Sales Volume VVOS|P/S Multiple NVNO (enVVeno Medical)|P/S Multiple Sintx Technologies Inc SINT|Tenon Medical - P/S Multiple|LFWD: Price-to-Revenue Ratio|autonomix.com (AMIX) - Price-to-Revenue Ratio|IVF (INVO Fertility Corp) - Price-to-Revenue Ratio|BBLG (Bone Biologics) - P/S Multiple|axonics.com (AXNX) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio BIOLASE (BIOL)|Price-to-Revenue Coefficient dynatronics.com|P/S Multiple FNA (Paragon 28)|Market Capitalization-to-Revenue Ratio INVO